{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:48:20Z","timestamp":1790711300986,"version":"4.1.0"},"reference-count":49,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T00:00:00Z","timestamp":1650844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"UTARRF","award":["4486\/000"],"award-info":[{"award-number":["4486\/000"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Mycobacteroides abscessus (formerly Mycobacterium abscessus) is a clinically important, rapid-growing non-tuberculous mycobacterium notoriously known for its multidrug-resistance phenotype. The intrinsic resistance of M. abscessus towards first- and second-generation tetracyclines is mainly due to the over-expression of a tetracycline-degrading enzyme known as MabTetX (MAB_1496c). Tigecycline, a third-generation tetracycline, is a poor substrate for the MabTetX and does not induce the expression of this enzyme. Although tigecycline-resistant strains of M. abscessus have been documented in different parts of the world, their resistance determinants remain largely elusive. Recent work on tigecycline resistance or reduced susceptibility in M. abscessus revealed the involvement of the gene MAB_3508c which encodes the transcriptional activator WhiB7, as well as mutations in the sigH-rshA genes which control heat shock and oxidative-stress responses. The deletion of whiB7 has been observed to cause a 4-fold decrease in the minimum inhibitory concentration of tigecycline. In the absence of environmental stress, the SigH sigma factor (MAB_3543c) interacts with and is inhibited by the anti-sigma factor RshA (MAB_3542c). The disruption of the SigH-RshA interaction resulting from mutations and the subsequent up-regulation of SigH have been hypothesized to lead to tigecycline resistance in M. abscessus. In this review, the evidence for different genetic determinants reported to be linked to tigecycline resistance in M. abscessus was examined and discussed.<\/jats:p>","DOI":"10.3390\/antibiotics11050572","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T21:16:28Z","timestamp":1650921388000},"page":"572","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Genetic Determinants of Tigecycline Resistance in Mycobacteroides abscessus"],"prefix":"10.3390","volume":"11","author":[{"given":"Hien Fuh","family":"Ng","sequence":"first","affiliation":[{"name":"Centre for Research on Communicable Diseases, Faculty of Medicine and Health Sciences, Universiti Tunku Abdul Rahman, Kajang 43000, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Fong","family":"Ngeow","sequence":"additional","affiliation":[{"name":"Centre for Research on Communicable Diseases, Faculty of Medicine and Health Sciences, Universiti Tunku Abdul Rahman, Kajang 43000, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,4,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1111\/j.1742-1241.2006.01188.x","article-title":"Tigecycline: A new glycylcycline antimicrobial","volume":"60","author":"Townsend","year":"2006","journal-title":"Int. J. Clin. Pract."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S303","DOI":"10.1086\/431672","article-title":"Tigecycline: A new glycylcycline for treatment of serious infections","volume":"41","author":"Noskin","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1128\/AAC.01499-05","article-title":"Functional, biophysical, and structural bases for antibacterial activity of tigecycline","volume":"50","author":"Olson","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1128\/AAC.04895-14","article-title":"Structural characterization of an alternative mode of tigecycline binding to the bacterial ribosome","volume":"59","author":"Schedlbauer","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/jac\/dkh125","article-title":"Comparison of tetracycline and tigecycline binding to ribosomes mapped by dimethylsulphate and drug-directed Fe2+ cleavage of 16S rRNA","volume":"53","author":"Bauer","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1128\/AAC.38.7.1658","article-title":"Inhibition of protein synthesis occurring on tetracycline-resistant, TetM-protected ribosomes by a novel class of tetracyclines, the glycylcyclines","volume":"38","author":"Rasmussen","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ijantimicag.2012.09.005","article-title":"The emergence of clinical resistance to tigecycline","volume":"41","author":"Sun","year":"2013","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1473-3099(10)70143-2","article-title":"Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: A molecular, biological, and epidemiological study","volume":"10","author":"Kumarasamy","year":"2010","journal-title":"Lancet Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1128\/AAC.46.10.3164-3167.2002","article-title":"Comparison of the In Vitro Activity of the Glycylcycline Tigecycline (Formerly GAR-936) with Those of Tetracycline, Minocycline, and Doxycycline against Isolates of Nontuberculous Mycobacteria","volume":"46","author":"Wallace","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/infdis\/jit614","article-title":"In Vivo Evaluation of Antibiotic Activity Against Mycobacterium abscessus","volume":"209","author":"Lerat","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/jac\/dku024","article-title":"Novel drug combination for Mycobacterium abscessus disease therapy identified in a Drosophila infection model","volume":"69","author":"Oh","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_12","first-page":"311","article-title":"In vitro effect of tigecycline against Mycobacterium tuberculosis and a review of the available drugs for tuberculosis","volume":"5","author":"Coban","year":"2011","journal-title":"Afr. J. Microbiol. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s40506-016-0092-6","article-title":"Nontuberculous Mycobacteria in Cystic Fibrosis","volume":"8","author":"Skolnik","year":"2016","journal-title":"Curr. Treat. Options Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/jac\/dkr578","article-title":"Mycobacterium abscessus: A new antibiotic nightmare","volume":"67","author":"Nessar","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e00119-18","DOI":"10.1128\/AAC.00119-18","article-title":"High Levels of Intrinsic Tetracycline Resistance in Mycobacterium abscessus Are Conferred by a Tetracycline-Modifying Monooxygenase","volume":"62","author":"Rudra","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijantimicag.2012.10.021","article-title":"Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan","volume":"41","author":"Huang","year":"2013","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"932","DOI":"10.3389\/fmicb.2018.00932","article-title":"Teicoplanin\u2013Tigecycline Combination Shows Synergy Against Mycobacterium abscessus","volume":"9","author":"Aziz","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1093\/jac\/dku062","article-title":"Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections","volume":"69","author":"Wallace","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1128\/AAC.01803-13","article-title":"Genomics of KPC-producing Klebsiella pneumoniae sequence type 512 clone highlights the role of RamR and ribosomal S10 protein mutations in conferring tigecycline resistance","volume":"58","author":"Villa","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/jac\/dkt319","article-title":"Decreased susceptibility to tigecycline in Acinetobacter baumannii mediated by a mutation in trm encoding SAM-dependent methyltransferase","volume":"69","author":"Chen","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s10096-014-2272-y","article-title":"Tigecycline resistance in Acinetobacter baumannii mediated by frameshift mutation in plsC, encoding 1-acyl-sn-glycerol-3-phosphate acyltransferase","volume":"34","author":"Li","year":"2015","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1093\/jac\/dkt263","article-title":"Mechanisms and fitness costs of tigecycline resistance in Escherichia coli","volume":"68","author":"Linkevicius","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"11829","DOI":"10.1021\/bi0506066","article-title":"Tigecycline is modified by the flavin-dependent monooxygenase TetX","volume":"44","author":"Moore","year":"2005","journal-title":"Biochemistry"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1128\/AAC.49.5.1865-1871.2005","article-title":"A novel MATE family efflux pump contributes to the reduced susceptibility of laboratory-derived Staphylococcus aureus mutants to tigecycline","volume":"49","author":"McAleese","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1093\/jac\/dkv211","article-title":"Induced tigecycline resistance in Streptococcus pneumoniae mutants reveals mutations in ribosomal proteins and rRNA","volume":"70","author":"Lupien","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1128\/JCM.02260-12","article-title":"Comparative drug resistance of Mycobacterium abscessus and M. chelonae isolates from patients with and without cystic fibrosis in the United Kingdom","volume":"51","author":"Broda","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Ananta, P., Kham-ngam, I., Chetchotisakd, P., Chaimanee, P., Reechaipichitkul, W., Namwat, W., Lulitanond, V., and Faksri, K. (2018). Analysis of drug-susceptibility patterns and gene sequences associated with clarithromycin and amikacin resistance in serial Mycobacterium abscessus isolates from clinical specimens from Northeast Thailand. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0208053"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1074\/jbc.M111.302588","article-title":"The mycobacterial transcriptional regulator whiB7 gene links redox homeostasis and intrinsic antibiotic resistance","volume":"287","author":"Burian","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"10062","DOI":"10.1093\/nar\/gkt751","article-title":"The mycobacterial antibiotic resistance determinant WhiB7 acts as a transcriptional activator by binding the primary sigma factor SigA (RpoV)","volume":"41","author":"Burian","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"12200","DOI":"10.1073\/pnas.0505446102","article-title":"Ancestral antibiotic resistance in Mycobacterium tuberculosis","volume":"102","author":"Morris","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1128\/AAC.00295-06","article-title":"Differential gene expression in response to exposure to antimycobacterial agents and other stress conditions among seven Mycobacterium tuberculosis whiB-like genes","volume":"50","author":"Geiman","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1128\/AAC.01353-17","article-title":"Antagonism between Front-Line Antibiotics Clarithromycin and Amikacin in the Treatment of Mycobacterium abscessus Infections Is Mediated by the whiB7 Gene","volume":"61","author":"Pryjma","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1046\/j.1365-2958.2003.03739.x","article-title":"RshA, an anti-sigma factor that regulates the activity of the mycobacterial stress response sigma factor SigH","volume":"50","author":"Song","year":"2003","journal-title":"Mol. Microbiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1099\/jmm.0.000857","article-title":"A mutation in anti-sigma factor MAB_3542c may be responsible for tigecycline resistance in Mycobacterium abscessus","volume":"67","author":"Ng","year":"2018","journal-title":"J. Med. Microbiol."},{"key":"ref_36","unstructured":"EUCAST (2018, August 07). Breakpoint Tables for Interpretation of MICs and Zone Diameters. Version 8. Available online: http:\/\/www.eucast.org."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"151380","DOI":"10.1016\/j.ijmm.2019.151380","article-title":"Tigecycline resistance may be associated with dysregulated response to stress in Mycobacterium abscessus","volume":"310","author":"Ng","year":"2020","journal-title":"Int. J. Med. Microbiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"001378","DOI":"10.1099\/jmm.0.001378","article-title":"A stop-gain mutation in sigma factor SigH (MAB_3543c) may be associated with tigecycline resistance in Mycobacteroides abscessus","volume":"70","author":"Lee","year":"2021","journal-title":"J. Med. Microbiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e0150921","DOI":"10.1128\/AAC.01509-21","article-title":"RNA-sequencing elucidates drug-specific mechanisms of antibiotic tolerance and resistance in M. abscessus","volume":"66","author":"Schildkraut","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1093\/jac\/dks196","article-title":"Bacterial stress responses as determinants of antimicrobial resistance","volume":"67","author":"Poole","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.1038\/ncomms5076","article-title":"ARTICLE Adaptive synonymous mutations in an experimentally evolved Pseudomonas fluorescens population","volume":"5","author":"Bailey","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"30334","DOI":"10.1074\/jbc.M114.606632","article-title":"Comprehensive Analysis of Stop Codon Usage in Bacteria and Its Correlation with Release Factor Abundance","volume":"289","author":"Korkmaz","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"5746","DOI":"10.1073\/pnas.100422497","article-title":"Protein oxidation in response to increased transcriptional or translational errors","volume":"97","author":"Dukan","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bbrc.2017.01.021","article-title":"Antibiotic tigecycline enhances cisplatin activity against human hepatocellular carcinoma through inducing mitochondrial dysfunction and oxidative damage","volume":"483","author":"Tan","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_45","first-page":"21","article-title":"Symbiotic theory of the origin of eukaryotic organelles; criteria for proof","volume":"29","author":"Margulis","year":"1975","journal-title":"Symp. Soc. Exp. Biol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Su\u00e1rez-Rivero, J.M., Pastor-Maldonado, C.J., Povea-Cabello, S., \u00c1lvarez-C\u00f3rdoba, M., Villal\u00f3n-Garc\u00eda, I., Talaver\u00f3n-Rey, M., Su\u00e1rez-Carrillo, A., Munuera-Cabeza, M., and S\u00e1nchez-Alc\u00e1zar, J.A. (2021). Mitochondria and Antibiotics: For Good or for Evil?. Biomolecules, 11.","DOI":"10.3390\/biom11071050"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Spooner, R., and Yilmaz, \u00d6. (2011). The Role of Reactive-Oxygen-Species in Microbial Persistence and Inflammation. Int. J. Mol. Sci., 12.","DOI":"10.3390\/ijms12010334"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Rohde, K.H., Veiga, D.F.T., Caldwell, S., Bal\u00e1zsi, G., and Russell, D.G. (2012). Linking the Transcriptional Profiles and the Physiological States of Mycobacterium tuberculosis during an Extended Intracellular Infection. PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1002769"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"8330","DOI":"10.1073\/pnas.102055799","article-title":"Reduced immunopathology and mortality despite tissue persistence in a Mycobacterium tuberculosis mutant lacking alternative sigma factor, SigH","volume":"99","author":"Kaushal","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/11\/5\/572\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:00:38Z","timestamp":1760137238000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/11\/5\/572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,25]]},"references-count":49,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["antibiotics11050572"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics11050572","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,25]]}}}